Rare Childhood Disorder Gets Its First FDA Drug Approval

(MedPage Today) — The FDA approved copper histidinate (Zycubo) as the first treatment for Menkes disease in pediatric patients, the agency announced Monday.
The treatment is a subcutaneous injectable formulation of copper histidine that aims…

Source link : https://www.medpagetoday.com/neurology/generalneurology/119404

Author :

Publish date : 2026-01-13 20:47:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

Rare Childhood Disorder Gets Its First FDA Drug Approval

FDA Says to Drop Suicide Warning From GLP-1 Drug Labels

Is There a Link Between Screen Use at Night and Suicide Risk in Kids?

Related Posts

Joss Reimer Becomes Canada’s Chief Public Health Officer

First Telerobotic Thrombectomy; Abnormal Cholesterol in Kids; Donated Heart Quirks

Misinformation Abounds in Influencers’ Promotion of Prescription Drugs

Obesity Drug Trial Dilemma; Tiny Insulin Pump Cleared; Type 5 Diabetes Deaths

European Code Against Cancer Targets Barriers to Prevention

Avapritinib’s Effect Durable in Indolent Systemic Mastocytosis

Joss Reimer Becomes Canada’s Chief Public Health Officer

First Telerobotic Thrombectomy; Abnormal Cholesterol in Kids; Donated Heart Quirks

Misinformation Abounds in Influencers’ Promotion of Prescription Drugs

Obesity Drug Trial Dilemma; Tiny Insulin Pump Cleared; Type 5 Diabetes Deaths

European Code Against Cancer Targets Barriers to Prevention

Avapritinib’s Effect Durable in Indolent Systemic Mastocytosis

The Tahoe Avalanche Tragedy: What Were They Thinking?

The shocking fossils that show T. rex wasn’t the king of the dinosaurs

Categories

Archives